-
公开(公告)号:EP3919056B1
公开(公告)日:2024-08-28
申请号:EP21185435.1
申请日:2014-03-10
IPC分类号: A61K31/437 , C07D213/46 , C07D211/70 , C07D211/40 , C07D207/12 , C07D207/08 , C07D213/74 , C07D498/08 , C07D405/04 , C07D413/04 , C07D401/04 , A61P7/00 , A61P43/00 , C07C65/30 , C07D213/30 , A61P3/00 , A61P9/10
CPC分类号: C07D401/14 , C07D405/14 , C07D401/12 , C07D213/30 , C07F7/0812 , C07C65/30 , C07D401/04 , A61K31/445 , A61K31/5375 , A61P11/00 , A61P3/00 , A61P35/00 , A61P43/00 , A61P7/00 , A61P9/10 , C07D207/08 , C07D211/40 , C07D211/70 , C07D213/46 , C07D207/12 , C07D265/32
-
公开(公告)号:EP3668863A1
公开(公告)日:2020-06-24
申请号:EP18762967.0
申请日:2018-08-13
发明人: LI, Zhe , YU, Ming , XU, Qing , ZANCANELLA, Manuel
IPC分类号: C07D403/12 , C07D401/14 , C07D405/14 , C07D219/10 , C07D221/06 , C07D401/12 , C07D413/12 , C07D471/04 , C07D471/08 , C07D491/044 , C07D491/056 , A61K31/473 , A61K31/4741 , A61K31/4375 , A61P35/00
-
33.
公开(公告)号:EP3141542B1
公开(公告)日:2020-05-27
申请号:EP16194019.2
申请日:2012-12-28
发明人: METCALF, Brian , CHUANG, Chihyuan , WARRINGTON, Jeffrey , PAULVANNAN, Kumar , JACOBSON, Matthew , HUA, Lan , MORGAN, Bradley
IPC分类号: A01N35/00 , A61K31/11 , C07D213/80 , C07D215/14 , C07C69/76 , C07D231/56 , C07D401/04 , C07C65/21 , A61K31/192 , A61K31/41 , A61K31/416 , A61K31/437 , A61K31/4406 , A61K31/4439 , A61K31/47 , A61K31/4985 , A61K31/235 , A61K31/445 , C07C65/30 , A61P7/06
-
34.
公开(公告)号:EP2797597B1
公开(公告)日:2020-02-26
申请号:EP12862096.0
申请日:2012-12-28
发明人: METCALF, Brian , CHUANG, Chihyuan , WARRINGTON, Jeffrey , PAULVANNAN, Kumar , JACOBSON, Matthew P. , HUA, Lan , MORGAN, Bradley
IPC分类号: A61K31/44 , C07D401/12 , C07D401/14 , C07D403/14 , C07D471/14 , C07D487/04
-
35.
公开(公告)号:EP3383392A1
公开(公告)日:2018-10-10
申请号:EP16813299.1
申请日:2016-12-02
IPC分类号: A61K31/4439 , A61K9/48 , A61P35/02
CPC分类号: A61K31/4439 , A61K9/1605 , A61K9/4858 , A61K9/4866
摘要: Provided herein are methods for treating sickle cell disease, comprising administering to a subject 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)-methoxy)benzaldehyde (Compound 1), or a polymorph thereof, in certain dosing regimens.
-
36.ALDEHYDE COMPOUNDS FOR TREATING PULMONARY FIBROSIS, HYPOXIA, AND CONNECTIVE TISSUE AND AUTOIMMUNE DISEASE 审中-公开
标题翻译: 用于治疗肺纤维化,低氧和连接组织及自身免疫疾病的醛类化合物公开(公告)号:EP3277379A1
公开(公告)日:2018-02-07
申请号:EP16714724.8
申请日:2016-03-29
发明人: LI, Zhe , HARRIS, Jason R. , DUFU, Kobina N. , GENG, Xin , SINHA, Uma
IPC分类号: A61P11/00 , A61P37/06 , A61P17/00 , A61P19/02 , A61K31/40 , A61K31/44 , A61K31/455 , A61K31/497 , C07D401/00
CPC分类号: A61K31/4439 , A61K31/40 , A61K31/44 , A61K31/4545 , A61K31/455 , A61K31/497 , A61K31/506 , C07D401/06 , C07D403/04
摘要: This disclosure relates to use of certain aldehyde compounds for treating pulmonary fibrosis, hypoxia, and connective tissue and autoimmune disease such as scleroderma, lupus, arthritis and related conditions in a mammal.
-
公开(公告)号:EP2968295A1
公开(公告)日:2016-01-20
申请号:EP14768961.6
申请日:2014-03-10
IPC分类号: A61K31/4427 , A61K31/4439 , A61K31/444 , A61P7/00
CPC分类号: A61K31/4427 , A61K31/4439 , A61K31/444
摘要: This invention provides pharmaceutical compositions for the aliosteric modulation of hemoglobin (S) and methods for their use in treating disorders mediated by hemoglobin (S) and disorders that would benefit from tissue and/or cellular oxygenation.
-
38.SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION 有权
标题翻译: 替补使用甲醛和方法组织氧合的增加公开(公告)号:EP2797416A4
公开(公告)日:2015-12-23
申请号:EP12862525
申请日:2012-12-28
发明人: METCALF BRIAN , CHUANG CHIHYUAN , WARRINGTON JEFFREY , PAULVANNAN KUMAR , JACOBSON MATTHEW P , HUA LAN , MORGAN BRADLEY
IPC分类号: A01N35/00 , A61K31/11 , C07C65/21 , C07C69/76 , C07D211/62 , C07D213/30 , C07D213/80 , C07D215/14 , C07D231/56 , C07D257/04 , C07D401/04 , C07D471/04 , C07D487/04
CPC分类号: A61K31/4985 , A61K31/192 , A61K31/235 , A61K31/41 , A61K31/416 , A61K31/437 , A61K31/4406 , A61K31/4439 , A61K31/445 , A61K31/47 , C07C65/30 , C07C69/76 , C07D211/62 , C07D213/30 , C07D213/80 , C07D215/14 , C07D231/56 , C07D257/04 , C07D401/04 , C07D471/04 , C07D487/04
摘要: Provided are substituted benzaldehydes and derivatives thereof of formula (I) that act as allosteric modulators of hemoglobin, methods and intermediates for their preparation, pharmaceutical compositions comprising the modulators, and methods for their use in treating disorders mediate by hemoglobin and disorders that would benefit from increased tissue oxygenation.
摘要翻译: 本发明提供substituiertem苯甲醛及其式(Ⅰ)所做动作的血红蛋白,方法和中间体其制备方法,药物组合物作为变构调节剂,其包括调制器,以及用于它们在治疗病症的使用方法的衍生物由血红蛋白调解和病症也将受益于 增加组织供氧。
-
39.SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION 审中-公开
标题翻译: 取代HETEROARYLALDEHYDVERBINDUNGEN和方法用于组织氧合的增加公开(公告)号:EP2797597A1
公开(公告)日:2014-11-05
申请号:EP12862096.0
申请日:2012-12-28
申请人: Global Blood Therapeutics, Inc. , Cytokinetics, Inc. , The Regents of the University of California
发明人: METCALF, Brian , CHUANG, Chihyuan , WARRINGTON, Jeffrey , PAULVANNAN, Kumar , JACOBSON, Matthew P. , HUA, Lan , MORGAN, Bradley
IPC分类号: A61K31/44
CPC分类号: C07D401/12 , C07D213/65 , C07D213/68 , C07D213/69 , C07D213/80 , C07D401/14 , C07D405/14 , C07D413/12 , C07D471/04 , C07D487/04
摘要: Provided are substituted heteroaryl aldehydes and derivatives thereof that act as allosteric modulators of hemoglobin, methods and intermediates for their preparation, pharmaceutical compositions comprising the modulators, and methods for their use in treating disorders mediate by hemoglobin and disorders that would benefit from increased tissue oxygenation.
-
公开(公告)号:EP3634962B1
公开(公告)日:2023-05-24
申请号:EP18735073.1
申请日:2018-06-07
发明人: YU, Chul , YU, Ming , ZANCANELLA, Manuel , LI, Zhe
IPC分类号: C07D471/04 , C07D487/04 , A61K31/519 , A61P7/00
-
-
-
-
-
-
-
-
-